Predictions are not my bag. But given the stellar pipeline and sales of Lympro underway, Eltoprazine IND underway, and ESS-W now onboard, I would be surprised if we do not break through .10 by the end of March. If we get a grant from MJFF or DOD or maybe the NIH it could easily take out .15 to .17......or maybe a lot higher....Momentum is clearly building. Stay tuned for news! Do your own DD and invest accordingly!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links